全文获取类型
收费全文 | 15012篇 |
免费 | 1551篇 |
国内免费 | 705篇 |
专业分类
耳鼻咽喉 | 164篇 |
儿科学 | 706篇 |
妇产科学 | 202篇 |
基础医学 | 4339篇 |
口腔科学 | 167篇 |
临床医学 | 1174篇 |
内科学 | 2804篇 |
皮肤病学 | 474篇 |
神经病学 | 977篇 |
特种医学 | 198篇 |
外国民族医学 | 6篇 |
外科学 | 586篇 |
综合类 | 1697篇 |
现状与发展 | 6篇 |
预防医学 | 430篇 |
眼科学 | 394篇 |
药学 | 597篇 |
1篇 | |
中国医学 | 50篇 |
肿瘤学 | 2296篇 |
出版年
2024年 | 42篇 |
2023年 | 221篇 |
2022年 | 512篇 |
2021年 | 632篇 |
2020年 | 599篇 |
2019年 | 600篇 |
2018年 | 499篇 |
2017年 | 566篇 |
2016年 | 605篇 |
2015年 | 666篇 |
2014年 | 878篇 |
2013年 | 1022篇 |
2012年 | 785篇 |
2011年 | 815篇 |
2010年 | 680篇 |
2009年 | 714篇 |
2008年 | 769篇 |
2007年 | 725篇 |
2006年 | 736篇 |
2005年 | 673篇 |
2004年 | 625篇 |
2003年 | 567篇 |
2002年 | 489篇 |
2001年 | 474篇 |
2000年 | 338篇 |
1999年 | 382篇 |
1998年 | 367篇 |
1997年 | 293篇 |
1996年 | 219篇 |
1995年 | 193篇 |
1994年 | 138篇 |
1993年 | 97篇 |
1992年 | 61篇 |
1991年 | 69篇 |
1990年 | 39篇 |
1989年 | 29篇 |
1988年 | 25篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 12篇 |
1980年 | 11篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1970年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Sofya N Pchelina Andrei F Yakimovskii Olga N Ivanova Anton K Emelianov Andrei H Zakharchuk Alexander L Schwarzman 《Movement disorders》2006,21(12):2234-2236
Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine-rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwestern region of Russia. Of these, 51 patients were probands from families with PD compatible with autosomal dominant inheritance. The control group represented 161 subjects without neurological disorders settled in the same region. The frequency of the G2019S mutation was greater in familial PD (2 [3.9%] of 51) than in sporadic PD (1 [0.6%] of 157). In addition, this mutation was found in the proband's father, who also had PD, in 1 PD family, and in 1 carrier without signs of PD at age 40 in another PD family. All carriers were heterozygous for the G2019S mutation and reported the Ashkenazi Jewish origin. The mutation was not found in the control group. 相似文献
52.
人心肌肌钙蛋白I第2和第4个密码子同义突变对其在大肠埃希菌中表达的影响 总被引:1,自引:1,他引:0
目的 对人心肌肌钙蛋白I(cTnI)基因实行定点突变并进行原核表达,观察此突变对cTnI表达量的影响。方法 利用RT-PCR方法从人心肌细胞的总RNA中克隆出编码人心肌肌钙蛋白I的cDNA片段,设计引物将其第2和第4个密码子突变后插入原核表达载体形成重组体,并导人宿主菌BL21(DE3)中,经IPTG诱导表达,Ni-NTA树脂纯化后行Western blot鉴定,观察突变对cTnI表达的影响。结果 突变后的cTnI基因与对照组相比在大肠埃希菌中得到高效表达,经纯化可获得电泳单点纯的cTnI蛋白。结论 成功克隆了cTnI基因,所设计的同义突变可促进cTnI在大肠埃希菌中的高效表达。 相似文献
53.
54.
Lorraine N Clark Eneli Haamer Helen Mejia-Santana Juliette Harris Suzanne Lesage Alexandra Durr Sabine Janin Bs Katja Hedrich Elan D Louis Lucien J Cote Howard Andrews Stanley Fahn Cheryl Waters Blair Ford Steven Frucht William Scott Christine Klein Alexis Brice Hanno Roomere Ruth Ottman Karen Marder 《Movement disorders》2007,22(7):932-937
Parkin mutations account for the majority of familial and sporadic early onset Parkinson's disease (EOPD) cases with a known genetic association. More than 100 mutations have been described in the Parkin gene that includes homozygous, compound heterozygous, and single heterozygous mutations. We have designed a Parkin mutation genotyping array (gene chip) that includes published Parkin sequence variants and allows their simultaneous detection. The chip was validated by screening 85 PD cases and 47 controls previously tested for Parkin mutations. Similar genotyping microarrays have been developed for other genetically heterogeneous diseases including age-related macular degeneration. Here, we show the utility of a genotyping array for Parkinson's disease by analysis of 60 subjects from the Genetic Epidemiology of Parkinson Disease (GEPD) study that includes 15 early-onset PD case probands and 45 relatives. 相似文献
55.
目的 探讨在单一拉米夫定 (LMV)干预下乙型肝炎相关性肝病肝移植后HBV再感染的发生 ,并分析其发生的易感因素。方法 随访 1999~ 2 0 0 3年接受肝移植并采用单一LMV防治HBV再感染的 6 3例乙肝相关性肝病患者 ,术后定期进行乙肝标志物、肝功能及HBVDNA定量检测 ,调查HBV再感染发生率并采用Logistic回归分析方法就术前诊断、病毒学资料及抗病毒治疗等分析其可能的易感因素。结果 在不同时期共出现HBV再感染 17例 ;各时间段HBV再感染率分别是 :6个月内9.5 % (6 / 6 3,其中 5例术后HBV标志物一直未阴转 ) ,6个月~ 1年 13.2 % (7/ 5 3) ,1~ 2年 2 7.8% (10 /36 ) ,2~ 3年 4 1.2 % (7/ 17) ,3年以上 6 0 .0 % (3/ 5 ) ;患者术前HBVDNA阳性及长期服用LMV与术后再感染呈正相关 (P <0 .0 5 ) ,而术前诊断、性别、年龄及血清HBsAg和HBeAg状态与HBV再感染则未发现显著相关性。结论 单一LMV预防HBV再感染对大多数肝移植者仍有效 ,但随术后存活时间的延长HBV再感染率呈现上升 ;术前使HBVDNA阴转及建立针对LMV耐药性变异的监测对防治再感染是必要的。 相似文献
56.
G. Xiromerisiou G. M. Hadjigeorgiou V. Gourbali J. Johnson I. Papakonstantinou A. Papadimitriou A. B. Singleton 《European journal of neurology》2007,14(1):7-11
Mutations in SNCA and LRRK2 genes, encoding alpha-synuclein and leucine-rich repeat kinase 2, respectively, cause autosomal dominant Parkinson's disease (AdPD). The LRRK2 G2019S (c.6055G > A) and R1441G (c.4321C > G) mutations have also been identified in sporadic PD (sPD). We studied 55 unrelated patients with AdPD, 235 patients with sPD, and 235 healthy age- and gender-matched controls all of Greek origin. Patients with AdPD were screened for SNCA and LRRK2 mutations by direct sequencing. SNCA gene dosage analysis was also performed for AdPD using quantitative duplex polymerase chain reaction of genomic DNA. In addition, we investigated the frequency of the LRRK2 G2019S mutation in sPD. We found no missense mutations or multiplications in the SNCA gene. Here we report two novel variants, A211V (c.632C > T) and K544E (c.1630A > G) in LRRK2 gene in two patients with AdPD that was not present in controls. We identified only one patient with sPD (1/235; 0.4%) carrying the G2019S mutation. LRRK2 mutations are present in AdPD and sPD patients of Greek origin. 相似文献
57.
58.
R. Gottschalk C. Seidl T. Löffler E. Seifried D. Hoelzer J.P. Kaltwasser 《Tissue antigens》1998,51(3):270-275
Abstract: Genetic hemochromatosis (GH) is closely associated with genes of the major histocompatibility complex (MHC) on chromosome 6. Recently, a candidate gene for GH, with structural similarities to MHC class I genes, designated HLA-H and presently named HFE, has been cloned. The HFE gene is localized telomeric to the MHC and several reports have indicated that the HFE gene is mutated in GH patients. In the present study we have analyzed the relationship of HFE gene variants and disease manifestation in GH patients and family members. Fifty-seven patients with GH, 73 family members and 153 healthy blood donors were studied for the amino acid dimorphism at codon 63 (His63Asp=H63D) and codon 282 (Cys282Tyr= C282Y) of the HFE gene. The codon 63 and 282 dimorphism were defined by PCR amplification of genomic DNA samples and restriction enzyme digestion using RsaI/SnaBI for C282Y and Bcll/Mbo 1 for H63D. Ferritin, transferrin serum levels and total iron-binding capacity were determined prior to therapeutic intervention. The Tyr-282 substitution occurred in 53 (93%) of patients compared with 8 (5.2%) of controls (OR=169, P >0.0001). Fifty-one (90%) patients were Tyr-282 homozygous. In contrast, the Asp-63 substitution was present in 5 (8.8%) of the patients compared with 34 (22%) of controls (OR=0.39, P =NS) with none of the patients being homozygous. In Tyr-282 homozygous GH patients serum ferritin levels, transferrin saturation, liver iron and liver iron index were elevated significantly compared to Tyr-282-negative patients, whereas no difference was observed between Tyr/Cys-282 heterozygous and Tyr-282-negative patients. 相似文献
59.
Androgenplaysanimportantroleinthenormaldevelopmentofmalephenotypeandtheregulationofvirilization.Theseactionsofandrogenaremediatedbytheintracellularandrogenreceptor(AR)containingN--terminal,DNAuandsteroidbindingdomains.MutationsintheARgenecancausevariousdegreesofandrogenInsensitivitysyndromes(AlS)inpatientswith46,XYkaryotype.ThephenotypeofpatientswithAlSrangesfromcompletefemaleexternalgenitalia(completeAlS,CAIS)overgenitalambiguity(partialAlS,PAlS)totheinfertilewithnormalmaleornearlys… 相似文献
60.